US3288564A - Method of removing inorganic iodine from blood - Google Patents

Method of removing inorganic iodine from blood Download PDF

Info

Publication number
US3288564A
US3288564A US289425A US28942563A US3288564A US 3288564 A US3288564 A US 3288564A US 289425 A US289425 A US 289425A US 28942563 A US28942563 A US 28942563A US 3288564 A US3288564 A US 3288564A
Authority
US
United States
Prior art keywords
sample
iodine
blood
inorganic iodine
precipitate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US289425A
Inventor
John E Leonard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beckman Coulter Inc
Original Assignee
Beckman Instruments Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Instruments Inc filed Critical Beckman Instruments Inc
Priority to US289425A priority Critical patent/US3288564A/en
Priority claimed from US289179A external-priority patent/US3235336A/en
Priority to GB25675/64A priority patent/GB1076793A/en
Priority to GB6718/67A priority patent/GB1076794A/en
Application granted granted Critical
Publication of US3288564A publication Critical patent/US3288564A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B7/00—Halogens; Halogen acids
    • C01B7/13—Iodine; Hydrogen iodide
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B7/00—Halogens; Halogen acids
    • C01B7/24—Inter-halogen compounds
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G5/00—Compounds of silver
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/19—Halogen containing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/19—Halogen containing
    • Y10T436/196666—Carbon containing compound [e.g., vinylchloride, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Definitions

  • This invention relates to a method for separating inorganic iodine from organic iodine in a blood sample and, more specifically, to a method of removing inorganic iodine from a blood sample so that the organic iodine content of the sample may be determined.
  • iodine in organic and biological materials is of very great importance, particularly in the medical-clinical field where organic iodine or proteinbound iodine (PBI), in blood is used as an indication of the functional condition of the thyroid gland. Since a blood sample contains both organic iodine and inorganic iodine, it is obviously necessary in determining the organic iodine content of the sample to initially remove the inorganic iodine.
  • the conventional method used today for removing inorganic iodine from a blood sample requires several steps, expensive equipment and skilled technicians.
  • zinc sulfate and sodium hydroxide are initially added to the sample to coagulate the protein out of the sample. Then, the sample is centrifuged and the supernatant liquid, which contains inorganic iodine, is poured off from the precipitate.
  • the precipitate contains the organic or protein-bound iodine, the amount of which is desired to be determined.
  • the organic iodine is generally determined by using the standard alkaline ash technique described in detail in copending patent application of Matsuyarna, entitled Method and Apparatus for Determining Iodine in Organic and Biological Materials, Serial No. 289,179, filed concurrently herewith, now Patent No. 3,235,336, and assigned to the same assignee as the present invention.
  • Another object of the present invention is to provide a simple and rapid method for removing inorganic iodine from a blood sample whereby the organic iodine remaining in the supernatant sample may be readily determined.
  • inorganic iodine may be separated from organic iodine by adding solid silver chloride to the blood sample, mixing and allowing a precipitate containing the inorganic iodine to settle out.
  • the solubility product constant (K s.p;) of silver chloride is approximately 10*
  • the chloride ion concentration in blood is about 0.09 to 0.11 molar, which will be assumed as being 0.1 molar for the purposes of this analysis.
  • the silver ion concentration will be approximately 10* M in accordance with the equations
  • the solubility product constant of silver iodide which is formed by the addition of silver chloride to a blood sample is about 10-"*.
  • the amount of silver chld ride added to a blood sample is not critical. All that is necessary is that enough silver chloride is added so that all the silver chloride does not dissolve in the sample, that is, the sample must be saturated with silver chloride to ensure that all the inorganic iodine in the blood reacts vto form a precipitate containing the inorganic iodine.
  • the sample must be saturated with silver chloride to ensure that all the inorganic iodine in the blood reacts vto form a precipitate containing the inorganic iodine.
  • 3 to 5 milligrams may be added to the blood sample to remove all the iodide from the sample.
  • the additional amount of silver chloride does not adversely afifect or contaminate the sample because of the limited solubility of Ag
  • the supernatant sample containing the protein-bound iodine may then be readily removed from the precipitate by merely pouring the supernatant from the precipitate.
  • the supernatant sample containing the FBI may then be treated to determine the protein-bound iodine content of the sample in accordance with the method described in said patent application of Matsuyama entitled Method and Apparatus for Determining Iodine in Organic and Biological Materials.
  • the sample containing the silver chloride it is preferable to shake the sample containing the silver chloride for a short period of time which permits the inorganic iodine in the sample to more quickly react.
  • the method of the present invention is obviously much more rapid than the conventional method requiring centrifuging utilized in laboratories today. Also, it is more rapid to precipitate the inorganic iodine from a blood sample than to pass the sample through a column containing an anion exchange resin as has been recently described.
  • the first column of Table I indicates the sample number whereas the second column indcates the protein-bound iodine content of the sample as determined by the conventional alkaline ash method utilized in the medical laboratories and clinics today and described in detail in said application of Matsuyama.
  • the third column of Table I shows the protein-bound iodine content of the blood samples as determined by adding silver chloride to the sample to remove the inorganic iodine from the sample in accordance with the novel method of the present invention and by determining the PBI content of the supernatant sample in accordance with the method described in said application of Matsuyama.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Description

United States Patent 3,288,564 METHOD OF REMOVING INORGANIC IODINE FROM BLOOD John E. Leonard, Fullerton, Califi, assignor to Beckman Instruments, Inc., a corporation of California No Drawing. Filed June 20, 1963, Ser. No. 289,425 6 Claims. (Cl. 23-230) This invention relates to a method for separating inorganic iodine from organic iodine in a blood sample and, more specifically, to a method of removing inorganic iodine from a blood sample so that the organic iodine content of the sample may be determined.
The determination of iodine in organic and biological materials is of very great importance, particularly in the medical-clinical field where organic iodine or proteinbound iodine (PBI), in blood is used as an indication of the functional condition of the thyroid gland. Since a blood sample contains both organic iodine and inorganic iodine, it is obviously necessary in determining the organic iodine content of the sample to initially remove the inorganic iodine.
The conventional method used today for removing inorganic iodine from a blood sample requires several steps, expensive equipment and skilled technicians. In order to separate the inorganic iodine from a blood sample by using the conventional method, zinc sulfate and sodium hydroxide are initially added to the sample to coagulate the protein out of the sample. Then, the sample is centrifuged and the supernatant liquid, which contains inorganic iodine, is poured off from the precipitate. The precipitate contains the organic or protein-bound iodine, the amount of which is desired to be determined. The organic iodine is generally determined by using the standard alkaline ash technique described in detail in copending patent application of Matsuyarna, entitled Method and Apparatus for Determining Iodine in Organic and Biological Materials, Serial No. 289,179, filed concurrently herewith, now Patent No. 3,235,336, and assigned to the same assignee as the present invention.
Recently, another method has been described for removing inorganic iodine from a blood sample. This method involves filling a glass column with an anion exchange resin, Amberlite, and flowing a blood sample through the column whereby the inorganic iodine is removed from the sample by an anion exchange reaction. The present invention involves still another manner by which inorganic iodine may be removed from a blood sample which has the advantage over the presently known methods of being more rapid and efiicient.
It is therefore the principal object of the present invention to provide a method for separating inorganic iodine from organic iodine in a blood sample.
Another object of the present invention is to provide a simple and rapid method for removing inorganic iodine from a blood sample whereby the organic iodine remaining in the supernatant sample may be readily determined.
According to the principal aspect of the present invention, it has been discovered that inorganic iodine may be separated from organic iodine by adding solid silver chloride to the blood sample, mixing and allowing a precipitate containing the inorganic iodine to settle out.
It is quite unexpected that the addition of silver chloride to a blood sample removes the inorganic iodine, that is iodide, from the sample. This can be best appreciated by considering the theoretical iodide content of blood, both before and after the addition of silver chloride. Normally there are about 1 to 2 micrograms of iodide in 100 ml. of blood. Thus, taking an average of about 1.5 micrograms of iodide in 100 ml. of blood, it is seen that the concentration of iodide Would be approximately 0.1 micromolar (,uM) which equals 10 molar.
3,288,554 Patented Nov. 29, 1966 The solubility product constant (K s.p;) of silver chloride is approximately 10* The chloride ion concentration in blood is about 0.09 to 0.11 molar, which will be assumed as being 0.1 molar for the purposes of this analysis. Thus, if silver chloride salt is placed into a blood sample, the silver ion concentration will be approximately 10* M in accordance with the equations The solubility product constant of silver iodide which is formed by the addition of silver chloride to a blood sample is about 10-"*. Thus, knowing that the silver ion concentration in blood saturated with AgCl is 10 M, then the resulting iodide concentration in the blood sample after the reaction of the silver chloride with iodide forming silver iodide is approximately 10-' M as is seen in the following equation It is thus seen that the maximum concentration of inorganic iodine theoretically should be 10- M when a blood sample is saturated with silver chloride, which concentration is approximately the same as the iodide concentration in blood before the addition of silver chloride. Thus, one would reasonably expect that silver chloride added to blood would not remove the inorganic iodine therefrom. However, contradictory to theoretical considerations, it has been unexpectedly found that when silver chloride is added to blood sample, it does remove substantially all the inorganic iodine from the sample.
It has also been found that the amount of silver chld ride added to a blood sample is not critical. All that is necessary is that enough silver chloride is added so that all the silver chloride does not dissolve in the sample, that is, the sample must be saturated with silver chloride to ensure that all the inorganic iodine in the blood reacts vto form a precipitate containing the inorganic iodine. For example, it has been found that only 2 micrograms of silver chloride need be added to a sample of 10 cc. of blood to separate out all the inorganic iodine from the blood sample. However, as a practical matter, it would be diflicult to measure out such small quantities of silver chloride. Therefore, 3 to 5 milligrams may be added to the blood sample to remove all the iodide from the sample. The additional amount of silver chloride does not adversely afifect or contaminate the sample because of the limited solubility of AgCl.
The supernatant sample containing the protein-bound iodine may then be readily removed from the precipitate by merely pouring the supernatant from the precipitate. The supernatant sample containing the FBI may then be treated to determine the protein-bound iodine content of the sample in accordance with the method described in said patent application of Matsuyama entitled Method and Apparatus for Determining Iodine in Organic and Biological Materials.
To increase the speed of removal of iodide, it is preferable to shake the sample containing the silver chloride for a short period of time which permits the inorganic iodine in the sample to more quickly react. The method of the present invention is obviously much more rapid than the conventional method requiring centrifuging utilized in laboratories today. Also, it is more rapid to precipitate the inorganic iodine from a blood sample than to pass the sample through a column containing an anion exchange resin as has been recently described.
In order to prove the accuracy of the present invention, many tests have been performed on blood samples to de- 7 termine the protein-bound iodine content of the samples after inorganic iodine has been removed therefrom, some of the results being indicated in Table I..
TABLE I g. Percent PBI Determined by Conventional Method ;tg. Percent PBI Determined by New Method Sample No.
The first column of Table I indicates the sample number whereas the second column indcates the protein-bound iodine content of the sample as determined by the conventional alkaline ash method utilized in the medical laboratories and clinics today and described in detail in said application of Matsuyama. The third column of Table I shows the protein-bound iodine content of the blood samples as determined by adding silver chloride to the sample to remove the inorganic iodine from the sample in accordance with the novel method of the present invention and by determining the PBI content of the supernatant sample in accordance with the method described in said application of Matsuyama. As can be seen, the results of the tests performed in accordance with the method of the present invention compares almost exactly to the results obtained by utilizing the conventional alkaline ash technique. As a pratcical matter, the very small diflerences which appear between these results are of virtually no consequence in the field of medical-clinical analysis.
Efforts have been made to see whether other salts having similar characteristics to silver chloride would be capable of removing the inorganic iodine from a blood sample. Silver bromide and mercurous chloride have been tried but without favorable results. Thus, even though silver chloride theoretically should not remove the inorganic iodine from a blood sample, it has been discovered that it does so with a high degree of efficiency and accuracy and, thus, there is provided by the present invention a very simple, efiicient and rapid means by which inorganic iodine may be removed from a blood sample whereby the supernatant sample may be tested for PBI content.
It will be understood that the details of the above description are intended as exemplary rather than limiting, and that various modifications of the method may be employed without departing from the spirit and scope of the invention as defined by the appended claims.
What is claimed is:
I. In a method for separating inorganic iodine from organic iodine in a blood sample, the steps of:
providing a sample of blood; placing solid AgCl into said sample to form a precipitate containing inorganic iodine; and allowing the precipitate to settle out. 2. In a method for separating inorganic iodine from organic iodine in a blood sample, the steps of:
providing a sample of blood; placing suificient solid AgCl into said sample to react with substantially all iodide in said sample to form a precipitate containing inorganic iodine; and allowing the precipitate to settle out. 3. In a method for separating inorganic iodine from organic iodine in a blood sample, the steps of:
providing a sample of blood; placing sufficient solid AgCl into said sample so that an excess of AgCl is present over the amount of which dissolves in the sample; and allowing a precipitate containing inorganic iodine to settle out. 4. In a method for separating inorganic iodine from organic iodine in a blood sample, the steps of:
providing a sample of blood; placing solid AgCl into said sample; shaking the sample containing AgCl to form a precipitate containing inorganic iodine; and allowing the precipitate to settle out. 5. In a method for removing inorganic iodine from a blood sample, the steps of:
providing a sample of blood; placing solid AgCl into said sample to form a precipitate containing inorganic iodine; allowing the precipitate to settle out; and removing the supernatant sample from said precipitate. 6. In a method for removing inorganic iodine from a blood sample, the steps of:
providing a sample of blood;
7 placing sufiicient AgCl into said sample to react with substantially all iodide in said sample to form a precipitate containing inorganic iodine;
shaking the sample containing AgCl to hasten the .for-
mation of said precipitate; and removing the supernatant sample from said precipitate.
References Cited by the Examiner UNITED STATES PATENTS 3,055,742 9/1962 Hamilton 23230 3,168,377 2/1965 Williams 23230 3,235,336 2/1966 Matsuyama 23--230 OTHER REFERENCES Barker et al.: The Clinical Determination of Protein- Bound Iodine, Journal of Clinical Investigation, vol. 30, 1951, pages 55-62.
Man et al.: Butanol-Extractable Iodin'e of Serum, Journal of Clinical Investigation, vol. 30, 1951, pages 531-538.
Tucker et al.: Concentration of Serum Protein-Bound Iodine in Normal Men, Journal of Clinical Investigation, vol. 30, 1951, pages 869-873.
JOSEPH SCOVRONEK, Acting Primary Examiner. Z. PAROCZAY, Assistqnt Examiner.

Claims (1)

1. IN A METHOD FOR SEPARATING INORGANIC IODINE FROM ORGANIC IODINE IN A BLOOD SAMPLE, THE STEPS OF: PROVIDING A SAMPLE OF BLOOD; PLACING SOLID AGCL INTO SAID SAMPLE TO FORM A PRECIPITATE CONTAINING INORGANIC IODINE; AND ALLOWING THE PRECIPITATE TO SETTLE OUT.
US289425A 1963-06-20 1963-06-20 Method of removing inorganic iodine from blood Expired - Lifetime US3288564A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US289425A US3288564A (en) 1963-06-20 1963-06-20 Method of removing inorganic iodine from blood
GB25675/64A GB1076793A (en) 1963-06-20 1964-06-22 Method and apparatus for separating iodine from organic and biological substances
GB6718/67A GB1076794A (en) 1963-06-20 1964-06-22 Method of separating inorganic iodine from organic iodine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US289425A US3288564A (en) 1963-06-20 1963-06-20 Method of removing inorganic iodine from blood
US289179A US3235336A (en) 1963-06-20 1963-06-20 Method and apparatus for determining iodine in organic and biological materials

Publications (1)

Publication Number Publication Date
US3288564A true US3288564A (en) 1966-11-29

Family

ID=26965491

Family Applications (1)

Application Number Title Priority Date Filing Date
US289425A Expired - Lifetime US3288564A (en) 1963-06-20 1963-06-20 Method of removing inorganic iodine from blood

Country Status (2)

Country Link
US (1) US3288564A (en)
GB (2) GB1076793A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3055742A (en) * 1959-01-28 1962-09-25 Clayton H Hamilton Simplified method for measuring protein-bound iodine
US3168377A (en) * 1960-05-12 1965-02-02 Beckman Instruments Inc Method for the determination of protein bound iodine
US3235336A (en) * 1963-06-20 1966-02-15 Beckman Instruments Inc Method and apparatus for determining iodine in organic and biological materials

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3055742A (en) * 1959-01-28 1962-09-25 Clayton H Hamilton Simplified method for measuring protein-bound iodine
US3168377A (en) * 1960-05-12 1965-02-02 Beckman Instruments Inc Method for the determination of protein bound iodine
US3235336A (en) * 1963-06-20 1966-02-15 Beckman Instruments Inc Method and apparatus for determining iodine in organic and biological materials

Also Published As

Publication number Publication date
GB1076793A (en) 1967-07-19
GB1076794A (en) 1967-07-19

Similar Documents

Publication Publication Date Title
Folch et al. A simple method for the isolation and purification of total lipides from animal tissues
GB969741A (en) Apparatus and method for separating certain components from blood
Gruenwedel et al. Complexing and denaturation of DNA by methylmereuric hydroxide. II. Ultracentrifugation studies
US3288564A (en) Method of removing inorganic iodine from blood
Tanaka et al. The formation constants of metal acetate complexes. II. Polarographic determination of the formation constants of acetatocopper (II), acetatolead (II) and acetatozinc (II) complexes
Singer et al. Studies on abnormal hemoglobins: VII. The composition of the non-S hemoglobin fraction in sickle-cell anemia bloods. A comparative quantitative study by the methods of electrophoresis and alkali denaturation
Bonner et al. Equilibrium studies of the silver-sodium-hydrogen system on Dowex 50
Kolthoff et al. A critical study of amperometric titration methods for sulfhydryl determination in native and denatured bovine serum albumin
US3426123A (en) Diagnostic test for infectious mononucleosis with aldehyde treated equine erythrocytes
Cope The Precipitation of Phenylmagnesium Bromide by Pyridine and by Dioxane
US3826821A (en) Reagents for the diagnosis of infectious mononucleosis and preparation of same
Thysell A COMPARISON BETWEEN ALBUSTIX, HEMA‐COMBISTIX, LABSTIX, THE SULPHOSALICYLIC‐ACID TEST, HELLER'S NITRIC‐ACID TEST, AND A BIURET METHOD: Diagnosis of Proteinuria
Searcy et al. Micro measurement of serum total lipids
US3055742A (en) Simplified method for measuring protein-bound iodine
JPS5924387B2 (en) Rheumatoid factor detection reagent゜
Kolosov et al. Cation-exchange method of determining the state of magnesium, calcium, and strontium in blood plasma
KR910008413A (en) Indirect aggregation immunoassay method and apparatus
JP7082544B2 (en) Method for eliminating bubbles generated in the reagent for measuring complement value and the reagent for measuring complement value
Sundararajan Investigations on the Determination of Protein-bound Calcium
SU614373A1 (en) Method of determining halogenide-ions
Nagel et al. Simplified automated solubility test for the detection of hemoglobin S applicable to mass screening
De Bruijn A standardized routine complement fixation test
Fukushi et al. Determination of Some Metal-EDTA Complexes by Capillary Type Isotachophoresis
Manwaring Qualitative Changes in the Third Serum Component
US3493346A (en) Method for testing for uric acid in blood